Bihm, C C; Williams, C L; Burks, T F (1998) Central actions of endomorphins: new endogenous opioids. Proc West Pharmacol Soc 41:81-3
|
Williams, C L; Rosenfeld, G C; Burks, T F (1997) Cholecystokinin-induced antinociception is not blocked by CCK-A or CCK-B receptor antagonists. Peptides 18:409-14
|
Shannon, M H; Bihm, C C; Short, W J et al. (1997) Interactions of oxytocin and vasopressin with CRF on the rat colon. Neuropeptides 31:94-8
|
Williams, C L; Bihm, C C; Rosenfeld, G C et al. (1997) Morphine tolerance and dependence in the rat intestine in vivo. J Pharmacol Exp Ther 280:656-63
|
Roerig, S C; Williams, C L; Hruby, V J et al. (1996) Inhibition of adenylyl cyclase activity by the cholecystokinin analog SNF 9007 in neuroblastoma x glioma NG108-15 hybrid cells. Regul Pept 61:51-6
|
Williams, C L; Cody, S; Burks, T F (1994) Stress-induced changes in gastrointestinal transit in mice are dependent on gender. Proc West Pharmacol Soc 37:73-6
|
Williams, C L; Rosenfeld, G C; Dafny, N et al. (1994) SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors. J Pharmacol Exp Ther 269:750-5
|
Kramer, T H; Davis, P; Hruby, V J et al. (1993) In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands. J Pharmacol Exp Ther 266:577-84
|
Kramer, T H; Toth, G; Haaseth, R C et al. (1991) Influence of peptidase inhibitors on the apparent agonist potency of delta selective opioid peptides in vitro. Life Sci 48:881-6
|
Ayres, E A; Parkhurst, D N; Fang, S et al. (1991) Antinociceptive and gastrointestinal transit effects of cholecystokinin (CCK-8) and related analogs of CCK-8 in the mouse. Proc West Pharmacol Soc 34:477-84
|
Showing the most recent 10 out of 79 publications